analyst
OP
NASDAQ · OPRX
OptimizeRx Corporation
Healthcare · Medical - Healthcare Information Services
$7.18
Down-$0.01 (-0.14%)
Updated Sep 11, 2026, 5:02 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 259.66M
- P/E ratio
- 7,647.53
- Dividend yield
- 0.00%
- 52-week range
- $4.54 – $9.08
- Volume
- 108.19K
- Avg. volume
- 304.06K
Price performance
OPRX price history
1M range · 20 trading sessions · Daily adjusted prices
OPRX closed at $7.18 after 20 trading sessions, down 18.22% for the selected period.
- Last close
- $7.18
- Period change
- -18.22%
- Period low
- $7.17
- Period high
- $8.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $7.07 | $7.26 | $6.86 | $7.18 | 108.19K |
| Sep 9, 2026 | $7.60 | $7.60 | $7.16 | $7.17 | 78.51K |
| Sep 8, 2026 | $7.84 | $7.84 | $7.56 | $7.60 | 99.96K |
| Sep 4, 2026 | $7.84 | $7.90 | $7.66 | $7.87 | 82.18K |
| Sep 3, 2026 | $8.09 | $8.335 | $7.90 | $7.95 | 157.81K |
| Sep 2, 2026 | $7.93 | $8.3499 | $7.48 | $8.04 | 171.64K |
| Sep 1, 2026 | $7.995 | $8.03 | $7.70 | $7.86 | 115.54K |
| Aug 31, 2026 | $7.89 | $8.04 | $7.7086 | $7.98 | 170.85K |
| Aug 28, 2026 | $7.83 | $8.09 | $7.60 | $7.95 | 271.58K |
| Aug 27, 2026 | $7.75 | $8.00 | $7.65 | $7.83 | 333.75K |
| Aug 26, 2026 | $7.78 | $7.85 | $7.62 | $7.75 | 112.88K |
| Aug 25, 2026 | $7.66 | $7.935 | $7.59 | $7.86 | 132.03K |
| Aug 24, 2026 | $7.71 | $8.10 | $7.60 | $7.65 | 150.32K |
| Aug 21, 2026 | $8.21 | $8.215 | $7.59 | $7.71 | 131.49K |
| Aug 20, 2026 | $7.98 | $8.2399 | $7.86 | $7.96 | 194.89K |
| Aug 19, 2026 | $8.31 | $8.89 | $8.01 | $8.01 | 208.04K |
| Aug 18, 2026 | $8.40 | $8.71 | $8.18 | $8.23 | 217.02K |
| Aug 17, 2026 | $8.71 | $8.82 | $8.43 | $8.48 | 139.52K |
| Aug 14, 2026 | $8.72 | $9.08 | $8.4505 | $8.72 | 386.07K |
| Aug 13, 2026 | $6.82 | $8.90 | $6.58 | $8.78 | 1.13M |
Latest OPRX news
The latest Smart Investors Daily articles mentioning OPRX.
Stock researchResearch & News · SEC Filings
Loading stock research…